+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1kzo | ||||||
---|---|---|---|---|---|---|---|
タイトル | PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYLATED K-RAS4B PEPTIDE PRODUCT AND FARNESYL DIPHOSPHATE SUBSTRATE BOUND SIMULTANEOUSLY | ||||||
![]() |
| ||||||
![]() | TRANSFERASE/TRANSFERASE SUBSTRATE / FTASE / PFT / PFTASE / FT / FPT / FARNESYLTRANSFERASE / FARNESYL TRANSFERASE / FARNESYL PROTEIN TRANSFERASE / CAAX / RAS / CANCER / PRODUCT / SUBSTRATE / TRANSFERASE-TRANSFERASE SUBSTRATE COMPLEX | ||||||
機能・相同性 | ![]() Apoptotic cleavage of cellular proteins / Inactivation, recovery and regulation of the phototransduction cascade / RAS processing / protein geranylgeranyltransferase activity / peptide pheromone maturation / protein farnesylation / protein geranylgeranyltransferase type I / CAAX-protein geranylgeranyltransferase activity / CAAX-protein geranylgeranyltransferase complex / protein farnesyltransferase ...Apoptotic cleavage of cellular proteins / Inactivation, recovery and regulation of the phototransduction cascade / RAS processing / protein geranylgeranyltransferase activity / peptide pheromone maturation / protein farnesylation / protein geranylgeranyltransferase type I / CAAX-protein geranylgeranyltransferase activity / CAAX-protein geranylgeranyltransferase complex / protein farnesyltransferase / protein farnesyltransferase activity / protein farnesyltransferase complex / Rab geranylgeranyltransferase activity / regulation of fibroblast proliferation / protein geranylgeranylation / positive regulation of skeletal muscle acetylcholine-gated channel clustering / geranylgeranyl diphosphate synthase activity / microtubule associated complex / forebrain astrocyte development / negative regulation of epithelial cell differentiation / type I pneumocyte differentiation / enzyme-linked receptor protein signaling pathway / regulation of synaptic transmission, GABAergic / epithelial tube branching involved in lung morphogenesis / Rac protein signal transduction / positive regulation of Rac protein signal transduction / skeletal muscle cell differentiation / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / alpha-tubulin binding / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / glial cell proliferation / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / SHC-mediated cascade:FGFR4 / Signaling by CSF3 (G-CSF) / Erythropoietin activates RAS / Signaling by FGFR4 in disease / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / protein-membrane adaptor activity / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / p38MAPK events / positive regulation of glial cell proliferation / Tie2 Signaling / FRS-mediated FGFR1 signaling / positive regulation of cell cycle / homeostasis of number of cells within a tissue / Signaling by FGFR2 in disease / striated muscle cell differentiation / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / Signaling by FLT3 fusion proteins / FLT3 Signaling / EGFR Transactivation by Gastrin / Signaling by FGFR1 in disease / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / GRB2 events in ERBB2 signaling / Downstream signal transduction / Ras activation upon Ca2+ influx through NMDA receptor / SHC1 events in ERBB2 signaling / Insulin receptor signalling cascade / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / VEGFR2 mediated cell proliferation / small monomeric GTPase / FCERI mediated MAPK activation / RAF activation / wound healing / regulation of long-term neuronal synaptic plasticity / Signaling by ERBB2 TMD/JMD mutants / Signaling by high-kinase activity BRAF mutants / Signaling by SCF-KIT / Constitutive Signaling by EGFRvIII / MAP2K and MAPK activation / : / Signaling by ERBB2 ECD mutants / visual learning / Signaling by ERBB2 KD Mutants / receptor tyrosine kinase binding / lipid metabolic process / cytoplasmic side of plasma membrane 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() | ||||||
手法 | ![]() ![]() | ||||||
![]() | Long, S.B. / Casey, P.J. / Beese, L.S. | ||||||
![]() | ![]() タイトル: The Reaction Path of Protein Farnesyltransferase at Atomic Resolution 著者: Long, S.B. / Casey, P.J. / Beese, L.S. #1: ![]() タイトル: The Basis for K-Ras4B Binding Specificity to Protein Farnesyltransferase Revealed by 2A Resolution Ternary Complex Structures 著者: Long, S.B. / Casey, P.J. / Beese, L.S. #2: ![]() タイトル: Crystal Structure of Protein Farnesyltransferase at 2.25A Resolution 著者: Park, H.W. / Boduluri, S.R. / Moomaw, J.F. / Casey, P.J. / Beese, L.S. #3: ![]() タイトル: Co-Crystal Structure of Mammalian Protein Farnesyltransferase with a Farnesyl Diphosphate Substrate 著者: Long, S.B. / Casey, P.J. / Beese, L.S. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 174.7 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 134.3 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
---|
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
| ||||||||
詳細 | The biological unit of protein farnesyltransferase (FTase) is a heterodimer of alpha and beta subunits. There is one FTase heterodimer per asymmetric unit. |
-
要素
-Protein Farnesyltransferase ... , 2種, 2分子 AB
#1: タンパク質 | 分子量: 44098.145 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() 発現宿主: ![]() ![]() 参照: UniProt: Q04631, squalene synthase |
---|---|
#2: タンパク質 | 分子量: 48722.281 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() 発現宿主: ![]() ![]() 参照: UniProt: Q02293, squalene synthase |
-タンパク質・ペプチド , 1種, 1分子 C
#3: タンパク質・ペプチド | 分子量: 1298.723 Da / 分子数: 1 / 由来タイプ: 合成 詳細: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS. 参照: UniProt: P01118, UniProt: P01116*PLUS |
---|
-非ポリマー , 5種, 432分子 








#4: 化合物 | ChemComp-ZN / |
---|---|
#5: 化合物 | ChemComp-FPP / |
#6: 化合物 | ChemComp-ACY / |
#7: 化合物 | ChemComp-FAR / |
#8: 水 | ChemComp-HOH / |
-詳細
Has protein modification | Y |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 3.12 Å3/Da / 溶媒含有率: 60.57 % | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 290 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 5.7 詳細: PEG 8000, Ammonium Acetate, Magnesium Chloride, DTT, Tris-HCl, pH 5.70, VAPOR DIFFUSION, HANGING DROP, temperature 290K | ||||||||||||||||||||
結晶化 | *PLUS 温度: 17 ℃ / pH: 5.7 / 詳細: Long, S.B., (2000) Structure, 8, 209. | ||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() |
検出器 | タイプ: RIGAKU RAXIS IV / 検出器: IMAGE PLATE / 日付: 2000年3月7日 / 詳細: Mirrors |
放射 | モノクロメーター: Ni Filter / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
反射 | 解像度: 2.2→50 Å / Num. obs: 56209 / % possible obs: 96 % / Observed criterion σ(I): -3 / 冗長度: 4.51 % / Biso Wilson estimate: 32.8 Å2 / Rsym value: 0.089 / Net I/σ(I): 16.1 |
反射 シェル | 解像度: 2.2→2.23 Å / 冗長度: 3.2 % / Mean I/σ(I) obs: 1.8 / Num. unique all: 1705 / Rsym value: 0.63 / % possible all: 87.9 |
反射 | *PLUS 最高解像度: 2.2 Å / 最低解像度: 50 Å / Num. measured all: 253335 / Rmerge(I) obs: 0.089 |
反射 シェル | *PLUS 最高解像度: 2.2 Å / 最低解像度: 2.3 Å / Rmerge(I) obs: 0.56 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: PDB entry 1D8D 解像度: 2.2→50 Å / Rfactor Rfree error: 0.004 / Data cutoff high absF: 10000000 / Data cutoff low absF: 0 / Isotropic thermal model: RESTRAINED / 交差検証法: THROUGHOUT / σ(F): 2 / 立体化学のターゲット値: Engh & Huber
| ||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 34.9 Å2
| ||||||||||||||||||||||||||||||||||||
Refine analyze |
| ||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.2→50 Å
| ||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||
LS精密化 シェル | 解像度: 2.2→2.3 Å / Rfactor Rfree error: 0.019 / Total num. of bins used: 8
| ||||||||||||||||||||||||||||||||||||
Xplor file |
| ||||||||||||||||||||||||||||||||||||
精密化 | *PLUS 最高解像度: 2.2 Å / 最低解像度: 50 Å / % reflection Rfree: 5 % / Rfactor all: 0.162 / Rfactor obs: 0.159 / Rfactor Rfree: 0.204 / Rfactor Rwork: 0.16 | ||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
| ||||||||||||||||||||||||||||||||||||
LS精密化 シェル | *PLUS 最高解像度: 2.2 Å / 最低解像度: 2.3 Å / Rfactor Rfree: 0.279 / Rfactor Rwork: 0.255 |